Cite Filings / VRDN
Feed Companies Filings Check
Sign in

CIK 0001590750 · Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471187261
Phone
617.272.4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Filings Insiders Search text
All 819 Financials 234 Shareholder Meetings 17 Executive Compensation 206 Insider Trading 264 Beneficial Ownership Interest 129 Business Combinations 189 Public Offerings 76 Mutual Funds and ETFs 13 Others 102
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-17
  3. DEF 14A Proxy Proxy Statement 2025-04-25
  4. DEF 14A Proxy Proxy Statement 2024-04-26
  5. DEF 14A Proxy Proxy Statement 2023-04-28
  6. DEF 14A Proxy Proxy Statement 2022-04-27
  7. DEF 14A Proxy Proxy Statement 2021-04-30
  8. DEF 14A Proxy Proxy Statement 2020-12-14
  9. DEF 14A Proxy Proxy Statement 2020-04-10
  10. DEF 14A Proxy Proxy Statement 2019-05-03
  11. DEF 14A Proxy Proxy Statement 2018-05-15
  12. DEF 14A Proxy Proxy Statement 2017-05-15
  13. DEF 14A Proxy Proxy Statement 2016-05-09
  14. DEF 14A Proxy Proxy Statement 2015-05-26

Page 1 of 1 · 13 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…